- Home
- CHMI vs APLT Comparison
CHMI vs APLT Comparison
Compare CHMI & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHMI
- APLT
- Stock Information
- Founded
- CHMI 2012
- APLT 2016
- Country
- CHMI United States
- APLT United States
- Employees
- CHMI N/A
- APLT N/A
- Industry
- CHMI Real Estate Investment Trusts
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- CHMI Real Estate
- APLT Health Care
- Exchange
- CHMI Nasdaq
- APLT Nasdaq
- Market Cap
- CHMI 89.2M
- APLT 44.0M
- IPO Year
- CHMI 2013
- APLT 2019
- Fundamental
- Price
- CHMI $2.73
- APLT $0.34
- Analyst Decision
- CHMI Hold
- APLT Buy
- Analyst Count
- CHMI 2
- APLT 7
- Target Price
- CHMI N/A
- APLT $6.10
- AVG Volume (30 Days)
- CHMI 340.8K
- APLT 2.5M
- Earning Date
- CHMI 08-07-2025
- APLT 08-06-2025
- Dividend Yield
- CHMI 21.98%
- APLT N/A
- EPS Growth
- CHMI N/A
- APLT N/A
- EPS
- CHMI N/A
- APLT N/A
- Revenue
- CHMI $27,506,000.00
- APLT $265,000.00
- Revenue This Year
- CHMI N/A
- APLT $1,768.13
- Revenue Next Year
- CHMI $54.92
- APLT $292.85
- P/E Ratio
- CHMI N/A
- APLT N/A
- Revenue Growth
- CHMI 19.59
- APLT N/A
- 52 Week Low
- CHMI $2.34
- APLT $0.30
- 52 Week High
- CHMI $3.95
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- CHMI 37.94
- APLT 46.28
- Support Level
- CHMI $2.68
- APLT $0.30
- Resistance Level
- CHMI $3.03
- APLT $0.36
- Average True Range (ATR)
- CHMI 0.08
- APLT 0.04
- MACD
- CHMI -0.02
- APLT 0.00
- Stochastic Oscillator
- CHMI 14.29
- APLT 39.56
About CHMI Cherry Hill Mortgage Investment Corporation
Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.